PUYLAERT KEVIN (Chief Sales Officer) sold 0.4% of their position (624.00 shares) of SOPHIA GENETICS SA on the open market
Open‑market sale worth $3.0K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 3 sales
Filed: 4/8/2026ACC: 0001840706-26-000127
Officer· Chief Sales Officer
Since Mar 2026
-624.00
Net shares
Net seller
$3.0K
Total sold
3
Open market trades
0B · 3S
3
Total transactions
624.00 disposed
Non-Derivative Transactions3
Ordinary Shares
Direct
Shares
−548.00
Price / share
$4.86
Trade value
$2.66K
% of position
0.4%
4/6/2026
148.85K→148.31K
Ordinary Shares
Direct
Shares
−46.00
Price / share
$4.86
Trade value
$223.56
% of position
0.0%
4/6/2026
148.31K→148.26K
Ordinary Shares
Direct
Shares
−30.00
Price / share
$4.83
Trade value
$144.90
% of position
0.0%
4/6/2026
148.26K→148.23K
Total
Net shares
−624.00
Net value
-$3.03K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Ordinary Shares Direct | 4/6/2026 | S · Sale | −548.00 | $4.86 | $2.66K | 0.4% | 148.85K | 148.31K |
| Ordinary Shares Direct | 4/6/2026 | S · Sale | −46.00 | $4.86 | $223.56 | 0.0% | 148.31K | 148.26K |
| Ordinary Shares Direct | 4/6/2026 | S · Sale | −30.00 | $4.83 | $144.90 | 0.0% | 148.26K | 148.23K |
| Total | −624.00 | -$3.03K | ||||||
Derivative Transactions0
No derivative transactions reported